A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single-Ascending-Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2017
At a glance
- Drugs TP 271 (Primary)
- Indications Pneumonia
- Focus Adverse reactions; First in man
- Sponsors Tetraphase Pharmaceuticals
- 05 Jun 2017 Results published in a Tetraphase Pharmaceuticals media release.
- 05 Jun 2017 According to a Tetraphase Pharmaceuticals media release, data from this single ascending-dose study were presented at the American Society for Microbiology (ASM) Mocrobe 2017.
- 08 Mar 2017 According to a Tetraphase Pharmaceuticals media release, status changed from recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History